Revisiting T-cell adhesion molecules as potential targets for cancer immunotherapy: CD226 and CD2

Y Jo, HI Sim, B Yun, Y Park, H ** - Experimental & Molecular Medicine, 2024 - nature.com
Cancer immunotherapy aims to initiate or amplify immune responses that eliminate cancer
cells and create immune memory to prevent relapse. Immune checkpoint inhibitors (ICIs) …

A guide to flow cytometry: components, basic principles, experimental design, and cancer research applications

L El‐Hajjar, F Ali Ahmad, R Nasr - Current Protocols, 2023 - Wiley Online Library
Flow cytometry (FCM) is a state‐of‐the‐art technique for the qualitative and quantitative
assessment of cells and other particles' physical and biological properties. These cells are …

Using Artificial Intelligence to Interpret Clinical Flow Cytometry Datasets for Automated Disease Diagnosis and/or Monitoring

YF Wang, JL Li, CC Lee, PK Wallace, BS Ko - Flow Cytometry Protocols, 2024 - Springer
Flow cytometry (FC) is routinely used for hematological disease diagnosis and monitoring.
Advancement in this technology allows us to measure an increasing number of markers …

Profile of CD150 expression in bone marrow cells of patients with acute myeloid leukemia

L Shlapatska, I Gordiienko, A Polishchuk… - Experimental …, 2022 - exp-oncology.com.ua
Background: Acute myeloid leukemia (AML) is a highly heterogeneous disease
accompanied by the arrest of myeloid cell lineage differentiation due to accumulation of …

[HTML][HTML] Identification of prognostic and driver gene mutations in acute myeloid leukemia by a bioinformatics analysis

L Li, J Ruan, N Zhang, J Dai, X Xu… - Translational Cancer …, 2023 - ncbi.nlm.nih.gov
Background The representative gene mutation in the prognostic groups of acute myeloid
leukemia (AML) patients is not yet known. The purpose of this study is to identify …

[PDF][PDF] Expression of aberrant markers in acute leukemia at south Egypt cancer institute: A retrospective study

MA Mohamed, EA Shafik, AO Ahmed… - SECI Oncol, 2021 - secioj.journals.ekb.eg
Background: Aberrant phenotypes in acute leukemia (AL) have variable frequency and their
prognostic relevance is controversial and dissimilar results have been reported by different …

“Friends and foes” of multiple myeloma measurable/minimal residual disease evaluation by next generation flow

P Pacelli, D Raspadori, E Bestoso, A Gozzetti… - Frontiers in …, 2022 - frontiersin.org
Next Generation Flow (NGF) represents a gold standard for the evaluation of Minimal
Residual Disease (MRD) in Multiple Myeloma (MM) patients at any stage of treatment …

Supervivencia e inmunofenotipos en pacientes con leucemias agudas diagnosticados por citometría de flujo en un hospital nivel III de Chiclayo Perú 2015-2019

JD Juárez Ynoñan - 2024 - repositorio.unprg.edu.pe
La inmunofenotipificación proporciona información importante para el diagnóstico,
clasificación y seguimiento de neoplasias hematológicas al permitir la identificación …

Flowcytometry Immunophenoty**: Role in Acute Leukemia and Detection of Aberrant Expressions in the Indian Population

N Singh, S Gohil, J Mathias… - Asian Hematology …, 2024 - asian.universityeprint.com
Aim: To study the distribution of Acute Leukemia cases, and the expression of commonly
used Cluster of Differentiation (CD markers) in sub-classification of Acute Leukemia and …

Flow cytometric Immunophenoty** and Hematological Findings at Diagnosis and Relapse of Pediatric Acute Lymphoblastic Leukemia Patients.

Z Gatavizadeh, M Faranoush… - Clinical …, 2020 - search.ebscohost.com
Background: Acute lymphoblastic leukemia (ALL) is a common pediatric leukemia caused
by lymphoid precursor proliferation. We analyzed immunophenoty** and hematological …